Cargando…
Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient
Beta-thalassemia is one of the most prevalent autosomal disorders, which affect more than 400,000 newborn per year worldwide. In India, the carrier rate of beta-thalassemia varies from 3-17%. The overall rate of alloimmunization in thalassemia patients has been reported to be 5-30% in the world, whi...
Autores principales: | Philip, Joseph, Jain, Neelesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140057/ https://www.ncbi.nlm.nih.gov/pubmed/25161355 http://dx.doi.org/10.4103/0973-6247.137454 |
Ejemplares similares
-
P1583: TRANSFUSIONS IN AUTOIMMUNE HEMOLYTIC ANEMIA: FREQUENCY AND CLINICAL SIGNIFICANCE OF ALLOIMMUNIZATION
por: Versino, Francesco, et al.
Publicado: (2023) -
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
por: Dhawan, Hari Krishan, et al.
Publicado: (2014) -
Comprehensive management of refractory autoimmune hemolytic anemia in pediatric beta-thalassemia major patient: A case report
por: William, Vincencius, et al.
Publicado: (2021) -
Alloimmunization in autoimmune hemolytic anemia patient: The differential adsorption approach
por: Dara, Ravi C., et al.
Publicado: (2017) -
Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)